These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1233 related articles for article (PubMed ID: 8825424)

  • 1. Alterations in endothelial cell proteinase and inhibitor polarized secretion following treatment with interleukin-1, phorbol ester, and human melanoma cell conditioned medium.
    Cottam DW; Corbitt RH; Gomez DE; Rees RC; Thorgeirsson UP
    J Cell Biochem; 1996 Jan; 60(1):148-60. PubMed ID: 8825424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
    Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
    Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma.
    Moser TL; Young TN; Rodriguez GC; Pizzo SV; Bast RC; Stack MS
    Int J Cancer; 1994 Feb; 56(4):552-9. PubMed ID: 8112891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between the F10, BL6 and F1 sublines of the B16 melanoma in the enhancement of plasminogen activator and plasminogen activator inhibitor secretion by phorbol myristate acetate.
    Hart DA; Smith R
    Cancer Lett; 1987 Apr; 35(1):27-38. PubMed ID: 3105864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of activated matrix metalloproteinase-2 by human endothelial cells after sublethal H2O2 exposure.
    Belkhiri A; Richards C; Whaley M; McQueen SA; Orr FW
    Lab Invest; 1997 Nov; 77(5):533-9. PubMed ID: 9389796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
    Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
    Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester.
    Hanemaaijer R; Koolwijk P; le Clercq L; de Vree WJ; van Hinsbergh VW
    Biochem J; 1993 Dec; 296 ( Pt 3)(Pt 3):803-9. PubMed ID: 8280080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of mouse L-cells with phorbol myristate acetate induces the secretion of a plasminogen activator inhibitor which binds to human and mouse urokinase and human tissue plasminogen activator.
    Rehemtulla A; Gates J; Hart DA
    Comp Biochem Physiol B; 1987; 88(1):277-83. PubMed ID: 3119281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells.
    Unemori EN; Bouhana KS; Werb Z
    J Biol Chem; 1990 Jan; 265(1):445-51. PubMed ID: 2152926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3.
    Cowell S; Knäuper V; Stewart ML; D'Ortho MP; Stanton H; Hembry RM; López-Otín C; Reynolds JJ; Murphy G
    Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):453-8. PubMed ID: 9531484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in expression of metalloproteinases and plasminogen activators in murine melanocytes and B16 melanoma variants: lack of association with in vitro invasion.
    Huijzer JC; Uhlenkott CE; Meadows GG
    Int J Cancer; 1995 Sep; 63(1):92-9. PubMed ID: 7558459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of radiation-impaired plasminogen activator release by phorbol ester in aortic endothelial cells.
    Raymond J; Yoon SC; Ts'ao CH
    Proc Soc Exp Biol Med; 1990 Nov; 195(2):213-7. PubMed ID: 2236104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cocultivation of human umbilical vein endothelial cells with Bowes melanoma cells.
    Addo-Boadu K; Christ G; Binder BR
    Ann N Y Acad Sci; 1992 Dec; 667():186-8. PubMed ID: 1309035
    [No Abstract]   [Full Text] [Related]  

  • 14. Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways.
    Montgomery AM; De Clerck YA; Langley KE; Reisfeld RA; Mueller BM
    Cancer Res; 1993 Feb; 53(3):693-700. PubMed ID: 8425205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of plasminogen activator inhibitor type 1 and type 1 collagen expression in rat cardiac microvascular endothelial cells by interleukin-1 and its dependence on oxygen-centered free radicals.
    Okada H; Woodcock-Mitchell J; Mitchell J; Sakamoto T; Marutsuka K; Sobel BE; Fujii S
    Circulation; 1998 Jun; 97(21):2175-82. PubMed ID: 9626179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
    Orbe J; Chordá C; Montes R; Páramo JA
    Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases.
    Jackson CJ; Nguyen M
    Int J Biochem Cell Biol; 1997 Oct; 29(10):1167-77. PubMed ID: 9438380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
    J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-type and tissue-type plasminogen activators have different distributions in cultured bovine capillary endothelial cells.
    Moscatelli D
    J Cell Biochem; 1986; 30(1):19-29. PubMed ID: 3082899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
    J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.